Expectations trend
FY2028 · fiscal year ending 2028-05-03 · fmp
Culp Inc (CULP)
NASDAQConsumer DiscretionaryManufacturing - TextilesSnapshot 2026-11-04
$3.64-4.71%
Close 2026-11-05 · 1-day change
NASDAQConsumer DiscretionaryManufacturing - TextilesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.01 → 0.01 EPS · FY ending May 3, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CULP yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
breakeven to positive adjusted EBITDA | A primary condition in Culp Inc's published investment case. The stated target is adjusted EBITDA >= 0. | Improving | adjusted EBITDA remains negative beyond next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-05-03 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a turnaround-style business, not yet a proven durable compounder. The multi-year view is on watch: management has made progress toward positive adjusted EBITDA, but recent performance remains weak and risk is elevated.
CULP is flagged as cheap versus peers, while the model also shows a 28% premium versus peers, a negative expectations gap, and low confidence. The priced-in tag is justified, with low fragility, but the evidence does not clearly show what specific operating assumptions the market expects.
Near term, the next results carry meaningful risk: the estimated chance of a miss is 43%, and the company has missed in recent quarters, despite a September earnings beat. For the multi-year thesis, sales growth and better cost control are encouraging: gross profit and adjusted EBITDA improved, and SG&A fell as a share of sales, though earnings quality remains loss-making.
The thesis depends on continued restructuring and integration gains, sustained revenue growth, and progress from breakeven toward positive adjusted EBITDA. Near term, a guidance cut would weaken the setup, while continued strength from sector bellwether UFI could support sector momentum; weaker UFI results could remove that support.
Over the next 1 to 3 years, CULP’s case rests on turning recent operating improvements into durable profitability, while managing weak demand and the risk of further estimate cuts. Evidence is mixed, and confidence in the valuation read is low. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Culp Inc's published investment case. The stated target is >=10 million USD annualized savings. |
| Improving |
| annualized savings fall below $10 million by 2025-Q4 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “- Adjusted EBITDA of $566 thousand, which does not include the benefit of tariff recoveries, compared to negative $(938) thousand in the prior-year period (see reconciliation table on page 11), reflecting much improved operating performance during the quarter.” “• The cost and efficiency benefits of restructuring and integration initiatives should drive improving gross profit and lower SG&A expenses, resulting in breakeven to positive adjusted EBITDA for the first quarter of fiscal year 2027 without the benefit of IEEPA tariff refunds.” Delivery assessment Nov 4, 2026 |
sequential and year-over-year revenue growth | A primary condition in Culp Inc's published investment case. The stated target is >=1.6% YoY revenue growth. | Intact | YoY revenue growth falls below 1.6% next year | Revenue growth: 6.47% FY2027-Q1; GAAP. Published target: >=1.6% YoY revenue growth. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Sep 11, 20266.474522 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Fiscal 2027 First Quarter Financial Highlights ▪ Year-over-year sales growth of 6.5%, while also overcoming one less selling week in the quarter, with consolidated net sales of $54.0 million compared to $50.7 million in the prior-year period and double-digit sales growth of 13.2% in the bedding segment.” “Fiscal 2026 Fourth Quarter Financial Highlights ▪ Consolidated net sales of $51.6 million, up 7.6% from third quarter sales of $48.0 million and up approximately 6% from prior-year period sales of $48.8 million, with bedding segment sales up approximately 12% sequentially and 12.5% year-over-year and upholstery segment sales up 2.1% sequentially and down 2.5% year-over-year.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.10 → $0.01 · observed estimates
$0.22B → $0.21B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-07-25 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-07-26 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-07-27 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-07-28 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-07-29 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-07-30 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-07-31 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-01 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-02 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-03 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-04 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-05 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-06 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-07 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-08 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-09 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-10 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-11 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-12 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-13 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-14 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-15 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-16 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-17 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-18 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-19 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-20 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-21 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-22 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-23 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-24 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-25 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-26 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-27 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-28 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-29 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-30 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-08-31 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-01 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-02 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-03 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-04 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-05 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-06 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-07 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-08 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-09 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-10 | $0.10 | $222,600,000 | 1 / 1 |
| 2026-09-11 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-12 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-13 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-14 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-15 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-16 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-17 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-18 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-19 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-20 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-21 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-22 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-23 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-24 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-25 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-26 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-27 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-28 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-29 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-09-30 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-01 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-02 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-03 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-04 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-05 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-06 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-07 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-08 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-09 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-10 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-11 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-12 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-13 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-14 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-15 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-16 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-17 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-18 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-19 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-20 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-21 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-22 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-23 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-24 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-25 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-26 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-27 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-28 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-29 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-30 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-10-31 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-11-01 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-11-02 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-11-03 | $0.01 | $213,612,000 | 1 / 1 |
| 2026-11-04 | $0.01 | $213,612,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.